Veridien Corporation Increases Investment in Anti-Infective/Drug Development Company - Mycosol, Inc.; Secures Rights to Acquire Majority Ownership.ST. PETERSBURG, Fla. -- Mycosol Has Five Patents Pending for Anti-Infective Technology Complementary to Veridien's Patented Products Veridien Corporation (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :VRDE) announced today that it has entered into an Agreement with Mycosol, Inc., a development-stage chemical and pharmaceutical company, located in the Research Triangle Park Research Triangle Park, research, business, medical, and educational complex situated in central North Carolina. It has an area of 6,900 acres (2,795 hectares) and is 8 × 2 mi (13 × 3 km) in size. Named for the triangle formed by Duke Univ. area of North Carolina. Veridien's focus is on anti-infectives - killing bacteria, mold, mildew, and viruses - through its Viraguard(R) product line of proprietary, alcohol-based liquid and towelette tow·el·ette n. A small, usually moistened piece of paper or cloth used for cleansing. antiseptics and disinfectants. Mycosol is developing complementary, non-alcohol-based technologies of safe, potent, long lasting products that it believes will not only kill, but retard the regrowth Re`growth´ n. 1. The act of regrowing; a second or new growth. The regrowth of limbs which had been cut off. - A. B. Buckley. of infective microbials - particularly mold. The 'core' chemistry was originally developed by the drug company, Burroughs Wellcome (now part of GlaxoSmithKline), and subsequently the data related thereto was licensed from GSK (NYSE NYSE See: New York Stock Exchange :GSK) by Mycosol. Mycosol has since developed and expanded this 'anti-infectives' technology, adding five patents pending and a myriad of potential industrial, agricultural, medical and veterinary applications. Under the Agreement, Veridien has initiated making equity investments in Mycosol with an option to acquire the majority ownership. Veridien will also have two seats on Mycosol's four-Director Board. Mycosol will continue to focus its technology on the further development of unique anti-microbials (bacteria, mold, yeast) to feed the Veridien product pipeline and distribution channels. Mycosol's 'Medical' opportunities include ongoing discussions with potential strategic partners to sub-license the development of proprietary, multi-activity drugs for topical anti-microbial and anti-inflammatory indications. 'Industrial' opportunities include two significant areas, namely mold remediation to address 'sick building' syndrome and the anti-mold pretreatment pretreatment, n the protocols required before beginning therapy, usually of a diagnostic nature; before treatment. pretreatment estimate, n See predetermination. of construction materials. Mycosol's CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Richard B. Klein B.S., M.S (Eng.), MBA stated: "The Viraguard(R) patented formulation is an excellent anti-infectives solution at a time when the public has an increasing need for that protection. We believe that the combination of our very experienced health industry management and synergistic technologies has the potential to greatly enhance the business and market opportunities for Veridien and Mycosol." About Veridien: Veridien Corporation is a Health Care and Anti-Infectives Company focusing on Infection Control and other Healthy Lifestyle products. Veridien has developed patented and unique products including surface disinfectants, antiseptic hand cleansers, instrument presoak pre·soak tr.v. pre·soaked, pre·soak·ing, pre·soaks To soak (laundry) before washing. n. 1. The act or an instance of presoaking. 2. A liquid preparation in which laundry is presoaked. , and sun protectant protectant /pro·tec·tant/ (pro-tek´tant) protective. protectant, protective 1. affording defense or immunity. 2. an agent affording defense against harmful influence. products. The flagship product, Viraguard(R) Hospital Disinfectant/Cleaner and Instrument Presoak is a skin friendly, patented, U.S. - EPA EPA eicosapentaenoic acid. EPA abbr. eicosapentaenoic acid EPA, n.pr See acid, eicosapentaenoic. EPA, n. and Health Canada registered, surface disinfectant. Viraguard(R) Antiseptic Hand Gel, Viraguard(R) Antiseptic Hand Spray and Viraguard(R) Antiseptic Hand Wipes are U.S. - FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. and Health Canada drug listed products utilizing Veridien's patented Virahol(R) formulation. Look for Veridien at http://www.veridien.com About Mycosol/Veridien's investment in future technology: Mycosol is a development-stage chemical and pharmaceutical company based in the Research Triangle Park area of North Carolina. The Company is developing a proprietary, low cost platform technology with the objective being to safely and effectively treat and prevent microbial-induced and microbial-exacerbated problems. Mycosol's proprietary, multi-active compound has demonstrated potent anti-fungal, anti-bacterial, anti-inflammatory, and anti-allergic properties. Using this 'core technology' platform, a library of over 1,500 known analogs and 5 patents pending, Mycosol believes that a broad portfolio of products can be developed for many medical, industrial, veterinary and agricultural applications. Look for Mycosol at http://www.mycosol.com Special Note: Forward-looking statements in this press release are made pursuant to the "safe-harbor" provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, market acceptance of, and demand for, the Company's products, manufacturing, development and distributor issues, product pricing, competition, funding availability, technological changes and other risks not identified herein. The Company disclaims any intent or obligation to update any forward-looking statements. "Healthy Living is an Adventure - Let Veridien Guide You" |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion